Ocuphire Pharma Inc (NASDAQ:OCUP)
| 3.82 BATS BZX Real-Time Price As of 10:28am ET |  -0.09 / -2.30%Today’s Change | 1.78 Today|||52-Week Range 6.60 | +8.22% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $85.9M |
Company Description
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.
Contact Information
Ocuphire Pharma, Inc. 37000 Grand River Avenue Farmington Hills Michigan 48335 |
Employees
Shareholders
| Mutual fund holders | 5.96% |
| Individual stakeholders | 5.90% |
| Other institutional | 10.72% |
Top Executives
| Richard J. Rodgers | President, Chief Executive Officer & Director |
| Bernhard Hoffmann | Vice President-Corporate Development & Operations |
| Amy Rabourn | Treasurer & Senior Vice President-Finance |
| Daniela Carmen Oniciu | Head- Research & Development |
| Mitchell Brigell | Head-Clinical Development & Strategy |
